Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigilance

Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children

(2011) Norio Sugaya et al.   JOURNAL OF INFECTION

Widespread use of neuraminidase inhibitors in Japan

(2011) Norio Sugaya   JOURNAL OF INFECTION AND CHEMOTHERAPY

Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection

(2010) N. Sugaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Long‐Acting Neuraminidase Inhibitor Laninamivir Octanoate versus Oseltamivir for Treatment of Influenza: A Double‐Blind, Randomized, Noninferiority Clinical Trial

(2010) Akira Watanabe et al.   CLINICAL INFECTIOUS DISEASES

Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage

(2010) Shinya Kimura et al.   JOURNAL OF EPIDEMIOLOGY

A potential competition bias in the detection of safety signals from spontaneous reporting databases

(2010) Antoine Pariente et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

CS-8958, a Prodrug of the Novel Neuraminidase Inhibitor R-125489, Demonstrates a Favorable Long-Retention Profile in the Mouse Respiratory Tract

(2009) K. Koyama et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oseltamivir treatment for children showing abnormal behavior during influenza virus infection

(2009) Takuya Tanabe et al.   BRAIN & DEVELOPMENT

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment

(2009) J. R. Smith et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico

(2009) Guillermo Domínguez-Cherit   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adolescent Jump Case in Japan Associated With Influenza but not Oseltamivir

(2009) Kihei Terada et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity

(2008) M. Yamashita et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir

(2008) Stephen Toovey et al.   DRUG SAFETY